DiaFocus System Feasibility Test

The DiaFocus system provides improved, and structured, communication between people with type-2 diabetes mellitus (T2DM) and healthcare professionals (HCP). The purpose of the study is to assess the feasibility, usefulness and usability of the system in a context of the T2DM at home and during everyday activities.



The aim of the DiaFocus system is threefold:

  1. To provide a platform that collects information about health-, behavior and emotional habits and status of people with type-2 diabetes. The includes sensor-based data collected from smartphone application, and self-reported assessments of wellbeing, emotional distress, and diabetes-related health behavior.
  2. To provide an improved communication between people T2DM and their HCP’s during regular consultations with emphasis on psycho-social factors and combination with health data, adapting to the Integrated Personalized Diabetes Management (iPDM) cycle.
  3. To allow personalized planning and goal setting in a patient-centered collaboration between a person with T2DM and their HCP motivating improved diabetes management, including quality of life and health outcomes.


DiaFocus is developed in Copenhagen Center for Health Technology (CACHET) as part of the Integrated Personalized Diabetes Management Goes Europe (iPDM-GO) project funded by EIT Health, involving a range of European partners. EIT Health is supported by the European Institute of Innovation and Technology (EIT), a body of the European Union that receives support from the European Union´s Horizon Europe Research and innovation programme.


The researcher team behind developing the system includes designers and engineers from The Technical University of Denmark (DTU), clinical staff at Steno Diabetes Center Copenhagen (SDCC), healthcare professionals at Center for Diabetes, City of Copenhagen (CFD) and health behavior experts at The University of Copenhagen (UCPH).


The study is a technical feasibility study and not a clinical study and will in no way replace existing treatment or provide a basis for clinical decision-making.


The study accepts Danish-speaking participants, diagnosed with type-2 diabetes mellitus and who are over the age of 18 or above. ~20 participants are recruited by the project partners at SDCC and CFD. Refer to the Danish-language participant information that can be downloaded from this page for more information.


Contact information

For practical and technical questions, refer to Claus Cramer-Petersen,, 2936 6838
12 JULY 2024